Monday, 21 January 2019

Lupin launches generic Silodosin Capsules 4mg and 8mg

06 December 2018 | News

Lupin's Silodosin Capsules 4mg and 8mg; is the generic equivalent of Allergan's Rapaflo

Lupin announced the launch of Silodosin Capsules 4mg and 8mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Silodosin Capsules 4mg and 8mg; is the generic equivalent of Allergan's Rapaflo®. An alpha-1 adrenergic receptor antagonist, it is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Rapaflo® had annual sales of $198.5 million in the US (IQVIA MAT September 2018).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account